These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Allogeneic bone marrow transplantation with a nonmyeloablative conditioning regimen in a patient with acute myeloblastic leukemia]. Rossiev VA, Aleksandrova IIa, Lipshina SR, Stukalova TA, Savchenko VG. Ter Arkh; 2000; 72(7):67. PubMed ID: 10983326 [No Abstract] [Full Text] [Related]
24. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease. Nestvold JM, Omdal BK, Dai KZ, Martens A, Benestad HB, Vaage JT, Rolstad B. Transplantation; 2008 Jan 15; 85(1):102-11. PubMed ID: 18192919 [Abstract] [Full Text] [Related]
28. [Relapse of acute leukemia after allogeneic bone marrow transplantation]. Tahara T, Yamazaki T, Abe A, Yamamoto K, Towatari M, Matsuoka A, Matsushita T, Kato H, Toyozumi H, Takeo T. Rinsho Ketsueki; 1994 Feb 15; 35(2):120-6. PubMed ID: 8139109 [Abstract] [Full Text] [Related]
29. Filgrastim for the treatment of leukemia relapse after bone marrow transplantation. Carral A, Sanz GF, Sanz MA. Bone Marrow Transplant; 1996 Oct 15; 18(4):817-9. PubMed ID: 8899204 [Abstract] [Full Text] [Related]
31. Adult allogeneic bone marrow transplantation: initial experience in the University Hospital, Kuala Lumpur. Teh A, Bosco JJ, Leong KW, Saw MH, Menaka N, Devashanti P. Med J Malaysia; 1997 Mar 15; 52(1):26-32. PubMed ID: 10968050 [Abstract] [Full Text] [Related]
32. [Bone marrow transplantation in the treatment of acute leukemias]. Moiseev SI, Ganapiev AA, Abdulkadyrov KM. Ter Arkh; 1996 Mar 15; 68(12):8-10. PubMed ID: 9054052 [Abstract] [Full Text] [Related]
33. Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia. Aversa F, Terenzi A, Tabilio A, Velardi A, Falzetti F, Felicini R, Carotti A, Ruggeri L, Reisner Y, Martelli MF. Bone Marrow Transplant; 1996 Mar 15; 17 Suppl 2():S58-61. PubMed ID: 8722339 [No Abstract] [Full Text] [Related]
36. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen. Matsuyama T, Kojima S, Kato K. Bone Marrow Transplant; 1998 Jul 15; 22(1):21-6. PubMed ID: 9678791 [Abstract] [Full Text] [Related]
37. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation. De Witte T, Schattenberg A, Preijers F, Raymakers R, Muus P, Wessels J. Bone Marrow Transplant; 1993 Jul 15; 12 Suppl 3():S2-6. PubMed ID: 8124252 [Abstract] [Full Text] [Related]
38. Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes. Kebriaei P, Kline J, Stock W, Kasza K, Le Beau MM, Larson RA, van Besien K. Bone Marrow Transplant; 2005 May 15; 35(10):965-70. PubMed ID: 15806131 [Abstract] [Full Text] [Related]
39. Esophageal graft versus host disease. Sodhi SS, Srinivasan R, Thomas RM. Gastrointest Endosc; 2000 Aug 15; 52(2):235. PubMed ID: 10922099 [No Abstract] [Full Text] [Related]
40. Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes. Kishi K, Takahashi S, Gondo H, Shiobara S, Kanamaru A, Kato S, Hirabayashi N, Moriyama Y, Harada M, Asano S, Hara H, Shibata A. Bone Marrow Transplant; 1997 Mar 15; 19(5):461-6. PubMed ID: 9052912 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]